Matthieu Grollemund

Matthieu Grollemund


Email [email protected]​

Phone +33 1 53 67 47 47

Fax +33 1 53 67 47 48

LanguagesEnglish, French, German

Practice groupCorporate & Finance

"He is very business-oriented and a deal-maker"

Chambers Europe 2020

Matthieu Grollemund is a Corporate partner in our Paris office and a member of our global Private Equity leadership team.

Triple qualified in French, US and UK law, he is a seasoned corporate lawyer active in complex and cross-border transactions. He advises private equity funds, companies, board of directors and senior managers in their most sensitive M&A transactions, IPOs, privately negotiated or hostile transactions involving public or private companies. He is particularly known in the Tech and Healthcare industries.

Prior to joining the firm, Matthieu Grollemund was Co-Head of the Paris Corporate Department of an international law firm. He also spent five years as a partner in a US-based global law firm in the New York office.

Awards and recognitions


Corporate/M&A (France), Foreign Expert for USA
Chambers Global


Lawyers specialised in LBOs (transactions on companies worth more than €300m) and innovation capital
Option Droit & Affaires


Ranked Individuals “Private Equity: Venture Capital in France”
Chambers Europe


Foreign Expert in Corporate/M&A (France and UK)
Chambers Global


Most Innovative Lawyers in Europe
Financial Times

Education and admissions


Corporate Law, University of Paris I Panthéon-Sorbonne, 1997

M.B.A., ESCP Paris, 1995

Bar admissions and qualifications


Solicitor, England and Wales

Licensed as a Foreign Legal Consultant, New York

Representative experience

Advised on a number of major tech transactions (Blablacar, Criteo, Doctolib, Mirakl, Ynsect, Ledger, Contentsquare, ManoMano, FarFetch, Exotec)*

Advised on a number of French and international IPO and offerings (AAA, Criteo, Navya, Farfetch)*

Advised on a number of public tender of offers (Zimmer Biomet on Medtech, Medtronic on Medicrea)*

Advised on the acquisition by Arch of a 30% block in Coface*

Advised Tencent on the acquisition of a minority interest in Ubisoft from Vivendi*

Advised ADM in the acquisition of Neovia from Invivo and Eurazeo for €1.4bn*

Advised in the disposition of Maesa to Bain capital*

Routinely advises a number of private equity funds on their growth and LBO investments mostly in the Tech, Life Science, Fintech and highly regulated industries*

*Matter handled prior to joining Hogan Lovells.

Loading data